Lymphoma in dogs, explained honestly and in full.

Lymphoma is a cancer of lymphocytes, white blood cells that are part of the immune system and travel throughout the body. Because those cells are everywhere, lymphoma behaves as a whole-body disease from the start, rather than a single lump you can cut out. The most common form in dogs is multicentric lymphoma, which shows up as firm, rubbery, painless enlargement of the lymph nodes, often first noticed under the jaw or behind the knees. Many dogs feel well at diagnosis, which is part of what makes the news so jarring.

The single most important detail on the biopsy is the immunophenotype: whether the cancer is a B-cell or a T-cell lymphoma. Most canine lymphomas are B-cell, which tends to respond better and last longer. T-cell disease generally behaves more aggressively. In a prospective study of 49 dogs, according to PubMed, immunophenotype was the only variable that significantly predicted survival, with T-cell disease carrying nearly four times the risk of a B-cell case (Dobson et al., Journal of Small Animal Practice, 2001). Your oncologist will also assign a stage and a substage, which further shape the outlook.

Here are the numbers, given straight. They are medians, the midpoint of a group: half the dogs did worse and half did better, sometimes by a wide margin. They describe populations treated in studies, not your individual dog.

Two honest caveats sit behind these figures. First, that large study found no meaningful difference between a shorter, discontinued protocol and a longer one with maintenance, which matters for cost and clinic visits (Lautscham et al., 2017). Second, these are averages across B-cell and T-cell dogs together; a B-cell dog often does better than the median, and a T-cell dog often does worse. Lymphoma is treatable and frequently goes into remission, but with standard therapy it is usually controlled rather than cured, and most dogs eventually relapse. For what a median does and does not promise, see how to read a canine cancer study.

The standard of care is multi-drug chemotherapy, most often a protocol called CHOP (a combination of cyclophosphamide, doxorubicin, vincristine, and prednisone given over several months). It is one of the success stories of veterinary oncology: most dogs tolerate it well, keep a good quality of life, and go into remission, often quickly. The goal is a good remission with a comfortable dog, not the punishing intensity of some human regimens.

For families who cannot pursue full chemotherapy, prednisone (a steroid) alone can shrink nodes and make a dog feel better for a while, but the benefit is usually much shorter and is about comfort rather than length of life. One important, often-missed point: starting steroids before a dog sees an oncologist can make later chemotherapy work less well. In that 408-dog study, corticosteroid pretreatment was linked to shorter survival (Lautscham et al., 2017). If chemotherapy is even a possibility, it is worth asking your veterinarian about the order of steps before steroids are started.

When lymphoma relapses, second-line, or rescue, protocols can bring some dogs back into remission, though usually for a shorter time. Your oncologist will match the plan to your dog's phenotype, stage, and how the disease has behaved.

Canine lymphoma is a leading comparative-oncology model for human non-Hodgkin lymphoma, so dogs often have access to clinical trials of new drugs and immunotherapies through university veterinary hospitals. If your dog is a candidate and you are interested, ask your oncologist what trials are enrolling.

A word on where our own work fits, honestly. RosieVaccine designs personalized neoantigen vaccines, an approach best suited to solid tumours with mutations to target, and lymphoma is primarily managed with chemotherapy rather than surgery. We mention it here only so the picture is complete: no cancer vaccine we design has published canine efficacy data, and nothing experimental changes the chemotherapy numbers above today. For most dogs with lymphoma, a well-run chemotherapy protocol with a good oncologist is the evidence-based path.

A few questions make the first oncology visit far more useful. Ask whether the lymphoma is B-cell or T-cell and what that means for your dog, what stage and substage it is, whether your dog is a good candidate for CHOP or a clinical trial, and, crucially, whether to wait on steroids until the plan is set. If any experimental option interests you, ask how a sample would need to be handled, following the receiving laboratory's own instructions.